1-3 of 3
Biao Zheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Follow-up Results of Brl-201 Phase I Study, a Crispr-Based Non-Viral PD-1 Locus Specific Integrated Anti-CD19 CAR-T Cells in Treating Relapsed or Refractory Non-Hodgkin's Lymphoma

Biao Zheng, Yongxian Hu, Jiqin Zhang, Mingming Zhang, Wei Li, Wenjun Wu, Jiazhen Cui, Guoqing Wei, Bing Du, Mingyao Liu, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2108.
https://doi.org/10.1182/blood-2023-185573
Published: 2023
Journal Articles

Efficacy and Safety of Brl-101, CRISPR-Cas9-Mediated Gene Editing of the BCL11A Enhancer in Transfusion-Dependent β-Thalassemia

Biao Zheng, Rongrong Liu, Xinhua Zhang, Bin Fu, Yajing Xu, Jun Shi, Xiaoqin Feng, Li Wang, Chris Wang, Rongmei Liang, Lingzhi Tan, Fei Wang, Dali Li, Yuxuan Wu, Mingyao Liu, Yongrong Lai
Journal: Blood
Blood (2023) 142 (Supplement 1): 4995.
https://doi.org/10.1182/blood-2023-186031
Published: 2023
Journal Articles

FTY720 suppresses humoral immunity by inhibiting germinal center reaction

Shuhua Han, Xuejun Zhang, Gangdou Wang, Hui Guan, Gabriela Garcia, Ping Li, Lili Feng, Biao Zheng
Journal: Blood
Blood (2004) 104 (13): 4129–4133.
https://doi.org/10.1182/blood-2004-06-2075
Published: 2004